Johnson & Johnson Covid-19 Vaccine Approved for Use in US – Overseas – News

The FDA approved the J&J vaccine the day after the FDA panel recommended its approval.

US President Joe Biden called the approval of the J&J vaccine “an encouraging development in our efforts to end this crisis.”

“However, we must not lose vigilance or assume that victory is imminent,” Biden warned in a statement from the White House.

The J&J vaccine is the third Covid-19 vaccine approved in the United States. The other two are vaccines from Pfizer and BioNTech, in addition to Moderna.

J&J plans to supply 20 million doses of these vaccines by the end of March and a total of 100 million doses in the first half of the year. It only takes one dose of the J&J vaccine to gain immunity.

The J&J vaccine is 66% effective, but 85% effective in preventing severe forms of Covid-19. This vaccine can be stored in a standard refrigerator, unlike the other two vaccines approved in the United States, it does not require a particularly low temperature.

To date, more than 47 million people in the United States have received at least one pot of Covid-19. The United States has a population of approximately 330 million.

Source link